Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
With this, the company can start selling Ibuprofen in the European markets.
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
Advancing to IND-enabling studies with multiple drug candidates
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
Novavax’ clinical development program reported no severe allergic reactions
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Subscribe To Our Newsletter & Stay Updated
